5502 Results

People

  1. O'Reilly
    O'Reilly
  2. Scheinberg
    Scheinberg
  3. Levine
    Levine
  4. Cheung
    Cheung
  5. Hricak
    Hricak
  6. Massague
    Massague
  7. Lewis
    Lewis
  8. Kernan
    Kernan
  9. Rudin
    Rudin
  10. Rajadhyaksha
    Rajadhyaksha

Groups

  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)
  7. Center for Hematologic Malignancies (1687)
  8. Sloan Kettering Institute Postdocs (1651)
  9. Hematologic Malignancies, Division of (1361)
  10. Molecular Pharmacology and Chemistry Program Faculty (1340)
  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Phase 1b dose escalation and expansion study of SNDX-5613, azacitidine (AZA) and venetoclax (VEN) in newly diagnosed, patients ≥ 60 years with untreated NPM1-mutated/ FLT3-wild type AML or KMT2A-rearranged acute myeloid leukemia (AML)
    Meeting Abstract

    Zeidner, J. F.; Foster, M. C.; Johnson, M.; Huang, Y.; Swords, R. T.; Stein, E.; Foran, J. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Updated efficacy and safety of tabelecleucel in patients with Epstein-Barr virus-positive (EBV(+)) leiomyosarcomas (LMS)
    Meeting Abstract

    Jimenez-Kurlander, L. S.; Behr, G.; Bunin, N. J.; Doubrovina, E.; Dinavahi, R.; Gamelin, L.; Ghobadi, A.; Mascarenhas, L.; Nikiforow, S.; O'Reilly, R. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Transfusion patterns during early follow-up predict overall survival independently of IPSS-M in patients with myelodysplastic syndromes
    Meeting Abstract

    Creignou, M.; Bernard, E.; Crowther, M.; Tranberg, A.; Ejerblad, E.; Nilsson, L.; Garelius, H.; Antunovic, P.; Hellström-Lindberg, B. E.; Lorenz, F.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The second generation type II JAK2 inhibitor, AJ1-10502, demonstrates enhanced selectivity, improved therapeutic efficacy and reduced mutant cell fraction compared to type I JAK2 inhibitors in models of myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Rai, S.; Stetka, J.; Usart, M.; Hao-Shen, H.; Park, Y.; Houston, R.; Martinez Benitez, A. R.; Wereski, M.; Guzzardi, E.; Persaud, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukaemia
    Meeting Abstract

    Leongamornlert, D.; Gutiérrez-Abril, J.; Lee, S.; Barretta, E.; Creasey, T.; Alapi, K. Z.; Levine, M. F.; Arango-Ossa, J. E.; Medina-Martinez, J. S.; Kirkwood, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Mutational profile of children with myeloproliferative neoplasms
    Meeting Abstract

    Rutherford, K.; Farnoud, N.; Krishnan, A.; Rampal, R. K.; Levine, R. L.; Kucine, N.
    Blood (2022)

    Fulltext@MSK | Save
  • Escape from type II JAK2 inhibition in MPN depends on AXL/MAPK activation and is targetable
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J.; Ghosh, N.; Buczak, K.; Passweg, J.; Angelillo-Scherrer, A.; Dirnhofer, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Long-term outcome of patients with follicular lymphoma is not fundamentally affected by KMT2D, EZH2, and CREBBP mutational status
    Meeting Abstract

    Bantilan, K. S.; Rutherford, K.; McCarter, J.; Farnoud, N.; Arango-Ossa, J. E.; Papaemmanuil, E.; Zelenetz, A. D.
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia
    Meeting Abstract

    Cruz-Rodriguez, N.; Kotini, A. G.; Carcamo, S.; Olszewska, M.; Bernard, E.; Luo, H.; Kharas, M. G.; Hasson, D.; Papapetrou, E. P.
    Blood (2022)

    Fulltext@MSK | Save